logo
appgoogle
EquityWireEarnings Review:Divi's Labs Q3 PAT growth slowest in 9 qtrs, misses estimate
Earnings Review

Divi's Labs Q3 PAT growth slowest in 9 qtrs, misses estimate

This story was originally published at 14:27 IST on 11 February 2026
Register to read our real-time news.
Earnings-Review-Divi-s-Labs-Q3-PAT-growth-slowest-in-9-qtrs-misses-estimate

Informist, Wednesday, Feb. 11, 2026

 

Please click here to read all liners published on this story
--Divi's Lab Oct-Dec net profit INR 5.98 bln 
--Analysts saw Divi's Lab Oct-Dec net profit at INR 6.34 bln 
--Divi's Lab Oct-Dec revenue INR 25.78 bln 
--Analysts saw Divi's Lab Oct-Dec revenue at INR 26.48 bln 
--Divi's Lab Oct-Dec net profit INR 5.98 bln vs INR 5.94 bln year ago 
--Divi's Lab Oct-Dec revenue INR 25.78 bln vs INR 22.97 bln year ago 
--Divi's Lab Apr-Dec net profit INR 18.51 bln vs INR 15.42 bln year ago 
--Divi's Lab Apr-Dec revenue INR 75.95 bln vs INR 66.62 bln year ago 
--Divi's Lab Oct-Dec labour code implementation cost INR 740 mln 
--Divi's Lab Oct-Dec profit excluding labour code impact INR 6.72 bln 
--Divi's Lab Oct-Dec forex gain INR 180 mln vs INR 110 mln year ago 


By Gunjan Rajput

 

MUMBAI – Divi's Laboratories Ltd. Wednesday reported a marginal rise in net profit for the December quarter, marking its slowest profit growth in nine quarters, even as revenue grew in double digits.

The company reported a net profit of INR 5.98 billion for the December quarter, up nearly 1% on year, but lower than analysts' estimate of INR 6.34 billion. Revenue for the December quarter was INR 25.78 billion, up over 12% on year. Revenue, too, was fell short of Street's expectation of INR 26.48 billion.

 

The company incurred a cost of INR 740 million towards labour code implementation during the quarter. Excluding this impact, net profit for the reporting quarter was INR 6.72 billion.  
 

The Hyderabad-based company's total expenses rose nearly 9% on year to INR 17.93 billion. The cost of materials consumed increased over 17% on year, while other expenses rose nearly 11% on year to INR 3.70 billion. Employee benefits expense climbed nearly 24% on year to INR 3.56 billion. Total income for the quarter stood at INR 26.65 billion, up over 12% from a year ago.


The company had foreign exchange gains of INR 180 million as of Dec. 31, higher than INR 110 million in the corresponding quarter last year. The company saw foreign exchange gains of INR 640 million in the September quarter. 

 

For Apr-Dec, Divi's Laboratories' net profit rose over 20% on year to INR 18.51 billion. The company's top line for the period rose 14% on year to INR 75.95 billion.

 

The company announced its December quarter results during market hours. At 1409, shares of the company traded at INR 6,301 per share on the National Stock Exchange, up 2% from the previous close.  End

 

IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT

 

Edited by Tanima Banerjee

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.

To read more please subscribe

Share this Story:

twitterlinkedinwhatsappmaillinkprint

Related Stories

Premium Stories

Subscribe